May 12, 2025: More Patients Sue Because of Side Effects of Ozempic and GLP-1 Products There are 1,809 lawsuits pending against the companies that made and sold Ozempic, the semaglutide medicine used to treat things like diabetes and obesity
PPG, postprandial plasma glucose
This results in a long half-life (approximately 7 days), making it suitable for once-weekly subcutaneous injection
Presented on 11 June 2019 during the 79th Scientific Sessions of the American Diabetes Association in San Francisco, USA
While highly effective for glycemic control and weight reduction, gastrointestinal adverse effects are commonly reported, with constipation rates varying by indication and dosageapproximately 3-9% in diabetes treatment (Ozempic, Rybelsus) and up to 24% in weight management (Wegovy)